| Title |
Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
|
|---|---|
| Published in |
Osteoporosis International, November 2014
|
| DOI | 10.1007/s00198-014-2964-2 |
| Pubmed ID | |
| Authors |
T. Sugimoto, T. Matsumoto, T. Hosoi, T. Miki, I. Gorai, H. Yoshikawa, Y. Tanaka, S. Tanaka, M. Fukunaga, T. Sone, T. Nakano, M. Ito, S. Matsui, T. Yoneda, H. Takami, K. Watanabe, T. Osakabe, N. Okubo, M. Shiraki, T. Nakamura |
| Abstract |
A 12-month extension phase of DIRECT in Japanese subjects with osteoporosis showed that total 3 years of denosumab treatment in Japanese postmenopausal women and men with osteoporosis was associated with low fracture rates, persistent bone turnover marker (BTM) reductions, continuous bone mineral density (BMD) increases, and a favorable overall benefit/risk profile. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| United Kingdom | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 131 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 16% |
| Student > Master | 18 | 14% |
| Researcher | 14 | 11% |
| Other | 13 | 10% |
| Student > Ph. D. Student | 10 | 8% |
| Other | 27 | 21% |
| Unknown | 28 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 40% |
| Nursing and Health Professions | 7 | 5% |
| Agricultural and Biological Sciences | 7 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Other | 17 | 13% |
| Unknown | 38 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2021.
All research outputs
#4,202,008
of 22,931,367 outputs
Outputs from Osteoporosis International
#684
of 3,626 outputs
Outputs of similar age
#60,177
of 363,333 outputs
Outputs of similar age from Osteoporosis International
#10
of 71 outputs
Altmetric has tracked 22,931,367 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,626 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,333 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.